Sexual side effects by treatment with psychotropic drugs;Seksuelle bivirkninger ved behandling med psykofarmaka

Ugeskrift for Laeger

Volumn 164, Issue 41, 2002, Pages 4753-4756

  Kristensen, Ellids ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; APOMORPHINE; CENTRAL STIMULANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; GINKGO BILOBA EXTRACT; GRANISETRON; LITHIUM; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; OXYTOCIN; PSYCHOTROPIC AGENT; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR MODIFICATION; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; HUMAN; PATIENT COMPLIANCE; PSYCHOPHARMACOTHERAPY; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION;

ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PSYCHOTROPIC DRUGS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 0037037354     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Pfaff DW. Drive: Neurobiological and Molecular Mechanisms of Sexual Motivation. New York: A Bradford Book, 1999.
2. Nedergaard P, Mellerup E. Receptorer og seksualitet. I: Graugaard C, Mohl B, Hertoft P, eds. Hjerne og Seksualitet. København: Munksgaard, 1997: 26-42.
3. Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: A double-blind, randomized, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21: 556-60.
4. Kafka MP, Hennen J. Psychostimulant augmentation during treatment with selective serotonin reuptake inhibitors in men with paraphilias and paraphilia-related disorders: A case series. J Clin Psychiatry 2000; 61: 664-70.
5. Crenshaw TL, Goldberg JP. Sexual Pharmacology: Drugs that Affect Sexual Functioning. New York: W.W. Norton, 1996: 307-16.
6. Lothstein LM, Fogg-Waberski J, Reynolds P. Risk management and treatment of sexual disinhibition in geriatric patients. Conn Med 1997; 61: 609-18.
7. Buckley PF. Sexuality and Serious Mental Illness. Cleveland: Harwood Academic Publishers, 1999.
8. Kristensen E. Neurofarmaka og seksualitet. I: Graugaard C, Møhl B, Hertoft P, eds. Hjerne og Seksualitet. København: Munksgaard 1997: 318-33.
9. Smith SM, O'Keane V, Murray R. Sexual dysfunction in patients taking conventional antipsychotic medication. Br J Psychiatry 2002; 181: 49-55.
10. Dickson RA, Glazer WM. Neuroleptic-induced hyperprolectinemia. Schizophrenia Research 1999; 35: 75-86.
11. Compton MT, Miller AH. Priapism associated with conventional and atypical antipsychotic medications: A review. J Clin Psychiatry 2001; 62: 362-6.
12. Møhl B, Kristensen E. Psykoser og seksualitet. I: Graugaard C, Møhl B, Hertoft P, eds. Hjerne og Seksualitet. København: Munksgaard, 1997:196-212.
13. Ferguson JM. The effects of antidepressants on sexual functioning in depressed patients: A review. J Clin Psychiatry 2001; 62 (suppl 3): 22-34.
14. Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F for the Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients. J Clin Psychiatry 2001; 62 (suppl 3): 10-21.
15. Elmore JL, Quattlebaum JT. Female sexual stimulation during antidepressant treatment. Pharmacotherapy 1997; 17; 612-6.
16. Kennedy SH, Eisfeld BS, Dickens SE, Bacchiochi JR, Bagby RM. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 2000; 61: 276-81.
17. Vanderkooy JD, Kennedy SH, Bagby RM. Antidepressant side effects in depression patients treated in a naturalistic setting: A study of bupropion, moclobemide, paroxetin, sertraline, and venlafaxine. Can J Psychiatry 2002; 47: 174-80.
18. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999; 19: 67-85.
19. Ekselius L, von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 2001; 21: 154-60.
20. Gelenberg AJ, Laukes C, McGahuey C, Okayli G, Moreno F, Zentner L et al. Mirtazapine substitution in SSRI-induced sexual dysfunction. J Clin Psychiatry 2000; 61: 356-60.
21. Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N et al. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 2001; 23: 1040-58.
22. Gold DD, Justino JD. "Bicycle kickstand" phenomenon: Prolonged erections associated with antipsychotic agents. South Med J 1988; 81: 792-4.
23. Haddad PM, Helleweil JS, Wieck A. Antipsychotic induced hyperprolactinaemia: A series of illustrative case reports. J Psychopharmacol 2001; 15: 293-5.
24. Hummer M, Kemmler G, Kurz M, Kurzthaler I, Oberbauer H, Fleischhacker WW. Sexual disturbances during clozapine and haloperidol treatment for schizophrenia. Am J Psychiatry 1999; 156: 631-3.
25. Green B. Focus on olanzapine. Curr Med Res Opin 1999; 15: 79-85.
26. Raja M. Risperidone-induced absence of ejaculation. Int Clin Psychopharmacol 1999; 14: 317-9.
27. Casey DE. Barriers to progress-the impact of tolerability problems. Int Clin Psychopharmacol 2001; 16 (suppl 1): 15-9.
28. Landen M, Eriksson E, Agren H, Fahler T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999; 19: 268-71.
29. Kristensen E, Jørgensen P. Sexual function in lithium-treated manicdepressive patients. Pharmacopsychiatry 1987; 20: 165-7.
30. Kristensen E, Jørgensen P. Seksuel dysfunktion forårsaget af lithium alene og i kombination med anden psykofarmaka. Nord Sex 1988; 6: 180-5.
31. Brannon GE, Rolland PD. Anorgasmia in a patient with bipolar disorder type 1 treated with gabapentin. J Clin Psychopharmacol 2000; 20: 379-81.
32. Zajecka J. Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin Psychiatry 2001; 62 (suppl 3): 35-43.
33. Hirschfeld RMA. Care of the sexually active depressed patient. J Clin Psychiatry 1999; 60 (suppl 17): 32-5.
34. Reynolds RD. Sertraline-induced anorgasmia treated with intermittent nefazodone. J Clin Psychiatry 1997; 58: 89.
35. Ostroff RB, Nelson JC. Risperidone augmentation of selective serotonin reuptake inhibitors in major depression. J Clin Psychiatry 1999; 60: 256-9.
36. Farah A. Relief of SSRI-induced sexual dysfunction with mirtazapin treatment. J Clin Psychiatry 1999; 60: 260-1.
37. Nurnberg HG, Gelenberg A, Hargreave TB, Harrison WM, Siegel RL, Smith MD. Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin reuptake inhibitors. Am J Psychiatry 2001; 158: 1926-8.
38. Gupta S, Droney T, Masand P, Ashton AK. SSRI-induced sexual dysfunction treated with sildenafil. Depress Anxiety 1999; 9: 180-2.
39. Shen WW, Urosevich Z, Clayton DO. Sildenafil in the treatment of female sexual dysfunction induced by selective serotonin reuptake inhibitors. J Reprod Med 1999; 44: 535-42.
40. Depatie L, Lal S. Apomorphine and the dopamine hypothesis of schizophrenia: A dilemma? J Psychiatry Neurosci 2001; 26: 203-20.